Harvard – Tectonic Therapeutic, License Agreement Post author:GHIAA Admin Post published:June 30, 2025 Post category: Continue ReadingHarvard – Tectonic Therapeutic, License Agreement
Atreca – Gates Medical Research Institute, Malaria Monoclonal Antibodies License Agreement Post author:GHIAA Admin Post published:June 26, 2025 Post category: Continue ReadingAtreca – Gates Medical Research Institute, Malaria Monoclonal Antibodies License Agreement
Valneva – Serum Institute of India, Chikungunya Vaccine License Agreement Post author:GHIAA Admin Post published:June 13, 2025 Post category: Continue ReadingValneva – Serum Institute of India, Chikungunya Vaccine License Agreement
Visterra – Serum Institute of India, Dengue Fever Therapeutic, License and Collaboration Agreement Post author:GHIAA Admin Post published:May 27, 2025 Post category: Continue ReadingVisterra – Serum Institute of India, Dengue Fever Therapeutic, License and Collaboration Agreement
ViiV – MPP, HIV Prevention Medicine (Cabotegravir LA for PrEP), License Agreement Post author:GHIAA Admin Post published:May 22, 2025 Post category: Continue ReadingViiV – MPP, HIV Prevention Medicine (Cabotegravir LA for PrEP), License Agreement
UCLA – Radiopharm Theranostics, Cancer Therapeutic & Diagnostic (DUNP19 antibody) License Agreement Post author:GHIAA Admin Post published:April 28, 2025 Post category: Continue ReadingUCLA – Radiopharm Theranostics, Cancer Therapeutic & Diagnostic (DUNP19 antibody) License Agreement
UK Lambert Toolkit, Model Consortium Agreement C Post author:GHIAA Admin Post published:March 20, 2025 Post category: Continue ReadingUK Lambert Toolkit, Model Consortium Agreement C
UK Lambert Toolkit, Model Consortium Agreement D Post author:GHIAA Admin Post published:March 17, 2025 Post category: Continue ReadingUK Lambert Toolkit, Model Consortium Agreement D
UK Lambert Toolkit, Model Consortium Agreement A Post author:GHIAA Admin Post published:March 17, 2025 Post category: Continue ReadingUK Lambert Toolkit, Model Consortium Agreement A